title: Skin manifestations associated with kidney cancer.
abstract: Kidney cancer is a heterogenous disease encompassing several distinct clinicopathologic entities with different underlying molecular aberrations and clinical outcomes. Renal cell carcinoma (RCC) has been shown to evoke immunologic responses that can impact the natural history of disease and clinical presentation. It is important to recognize atypical presentations of disease, including cutaneous manifestations. The incidence of skin metastases from RCC is low, yet needs to be appreciated in the appropriate setting; clinical presentation for these lesions is reviewed briefly. There are several hereditary syndromes that present with well characterized cutaneous lesions and are associated with an increased risk for RCC, including Von Hippel-Lindau and Birt-Hogg-Dubé syndromes. Given that these skin lesions may be the first presenting sign for RCC, timely recognition is of essence and both are discussed in some detail. Several therapeutic options based on immunomodulation are approved for the treatment of advanced RCC. Dermatologic toxicities observed with these agents are also briefly discussed.
authors.affiliation: Levine Cancer Institute at Carolinas Medical Center, Charlotte, NC. Electronic address: Asim.Amin@Carolinashealthcare.org.
authors.forename: Asim
authors.initials: A
authors.lastname: Amin
authors.affiliation: Levine Cancer Institute at Carolinas Medical Center, Charlotte, NC.
authors.forename: Earle F
authors.initials: EF
authors.lastname: Burgess
mesh_terms: D002292:Carcinoma, Renal Cell / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods; D009386:Neoplastic Syndromes, Hereditary / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology* / Q000556:secondary / Q000628:therapy
chemical_list: D007376:Interleukin-2
keywords: Birt-Hogg-Dubé syndrome; Hereditary leiomyomatosis and renal cell carcinoma; Renal cell carcinoma; Von Hippel-Lindau